These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10816089)

  • 1. An overview of bioactivation of chemical carcinogens.
    Glatt HR
    Biochem Soc Trans; 2000 Feb; 28(2):1-6. PubMed ID: 10816089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfotransferases in the bioactivation of xenobiotics.
    Glatt H
    Chem Biol Interact; 2000 Dec; 129(1-2):141-70. PubMed ID: 11154739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfotransferases: genetics and role in toxicology.
    Glatt H; Engelke CE; Pabel U; Teubner W; Jones AL; Coughtrie MW; Andrae U; Falany CN; Meinl W
    Toxicol Lett; 2000 Mar; 112-113():341-8. PubMed ID: 10720750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly selective bioactivation of 1- and 2-hydroxy-3-methylcholanthrene to mutagens by individual human and other mammalian sulphotransferases expressed in Salmonella typhimurium.
    Meinl W; Tsoi C; Swedmark S; Tibbs ZE; Falany CN; Glatt H
    Mutagenesis; 2013 Sep; 28(5):609-19. PubMed ID: 23894158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems.
    Glatt H; Bartsch I; Christoph S; Coughtrie MW; Falany CN; Hagen M; Landsiedel R; Pabel U; Phillips DH; Seidel A; Yamazoe Y
    Chem Biol Interact; 1998 Feb; 109(1-3):195-219. PubMed ID: 9566746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation.
    Glatt H
    FASEB J; 1997 Apr; 11(5):314-21. PubMed ID: 9141497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of human sulfotransferases in the bioactivation of nitro- and aminotoluenes.
    Glatt H; Sabbioni G; Monien BH; Meinl W
    Environ Mol Mutagen; 2016 May; 57(4):299-311. PubMed ID: 26924705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens.
    Banoglu E
    Curr Drug Metab; 2000 Jul; 1(1):1-30. PubMed ID: 11467078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods.
    Herrmann K; Engst W; Appel KE; Monien BH; Glatt H
    Mutagenesis; 2012 Jul; 27(4):453-62. PubMed ID: 22337896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfotransferases and acetyltransferases in mutagenicity testing: technical aspects.
    Glatt H; Meinl W
    Methods Enzymol; 2005; 400():230-49. PubMed ID: 16399352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolizing systems in short-term in vitro tests for carcinogenicity.
    Platt KL; Utesch D; Gemperlein-Mertes I; Glatt HR; Oesch F
    Food Chem Toxicol; 1986; 24(6-7):721-9. PubMed ID: 3781425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium.
    Meinl W; Meerman JH; Glatt H
    Pharmacogenetics; 2002 Dec; 12(9):677-89. PubMed ID: 12464797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes.
    Glatt H; Pabel U; Meinl W; Frederiksen H; Frandsen H; Muckel E
    Carcinogenesis; 2004 May; 25(5):801-7. PubMed ID: 14729582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase.
    Arlt VM; Glatt H; Muckel E; Pabel U; Sorg BL; Schmeiser HH; Phillips DH
    Carcinogenesis; 2002 Nov; 23(11):1937-45. PubMed ID: 12419844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity.
    Glatt H; Meinl W
    Carcinogenesis; 2004 May; 25(5):779-86. PubMed ID: 14754874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemical carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100.
    Kranendonk M; Commandeur JN; Laires A; Rueff J; Vermeulen NP
    Mutagenesis; 1997 Jul; 12(4):245-54. PubMed ID: 9237769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
    Inami K; Mochizuki M
    Mutat Res; 2002 Aug; 519(1-2):133-40. PubMed ID: 12160898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity testing with Salmonella microsome test.
    Greim H; Göggelmann W; Summer KH; Wolff T
    Arch Toxicol; 1980 Nov; 46(1-2):31-40. PubMed ID: 7016073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.